Based on these ideas we systematically tested impact of cblb-deficiency on the biological behaviour of murine DCs to finally evaluate whether anti-tumor responses could further be improved by using cblb−/− DCs instead of wildtype DCs for vaccination. The gene discussed is CBLB; the disease is neoplasm.